Industrial

France-based chemicals company Arkema has sold its stake in US-based medical technologies group Oxford Performance Materials (OPM).

PTT Chemical owns 47.9% of Myriant after it invested $60m in January.

The Indian unit of US-based publisher International Data Group finds that technology deals make more than five times investors' money in the region.

Valero joins existing strategic investor Waste Management, a US-listed garbage collection company, and venture capital firms Rho Ventures, Braemar Energy Ventures and Cycle Capital, who have all invested in the latest equity round.

Corporations venture into a world of innovation at the inaugural Symposium on May 18, 2011, at the Emirates Stadium (pictured), London, UK.

To report a deal in Global Corporate Venturing, contact James Mawson at jmawson@globalcorporateventuring.com

Venture philanthropy comes of age in medical hour of need

Eli Lilly's first portfolio company acquisition

Cleveland Clinic allies with MedStar

"This is a time for great opportunities to develop novel diagnostic tools, therapeutic agents and medical devices for unmet patients' needs, and that a diversified, multidisciplinary team is a must to develop these opportunities."

London's global appeal as a cultural centre with relative tolerance, combined with its research base across the Golden Triangle, gives it access to scientific and entrepreneurial talent to capitalise on the combination of complicated technology with soft-information skills from media and other services.